Jade Biosciences (JBIO) PT Raised to $40 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts JBIO Hot Sheet
Price: $14.39 +1.70%
Rating Summary:
11 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
11 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Jefferies analyst Akash Tewari raised the price target on Jade Biosciences (NASDAQ: JBIO) to $40.00 (from $16.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: just concluded a highly successful discussion with president Vladimir Putin
- Trans Canada Gold closes first tranche of private placement at C$2.1M
- EquipmentShare disputes short seller report as false and misleading
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Jefferies & Co, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
